Ischemic Stroke as a Complex Genetic Disorder

ABSTRACT

Ischemic stroke is a complex genetic disorder, diverse in pathophysiology and clinical presentation. This phenotypic diversity may reflect genotypic diversity. One approach to discovering genetic risk factors has been to study intermediate phenotypes as in carotid intima-media thickness and leukoaraiosis. Intermediate phenotypes can be highly heritable, assessed in stroke-affected and unaffected individuals, and analyzed as quantitative traits. Because there is not a one-to-one relationship between intermediate phenotypes and ischemic stroke, polymorphisms or haplotypes associated with an intermediate phenotype should be validated as risk factors for stroke itself. A complementary approach to gene discovery has been to fractionate the ischemic stroke phenotype into more homogeneous subphenotypes. Family history studies suggest that some subphenotypes like cardioembolic stroke may be less heritable than others.

KEYWORDS

Ischemic stroke - phenotypic variability - family history - classification - genetic research - genomic research - intermediate phenotypes

REFERENCES

• 1 Flossmann E, Schulz U G, Rothwell P M. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke.  Stroke. 2004;  35 212-227
• 2 Hassan A, Lansbury A, Catto A J et al.. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes.  J Neurol Neurosurg Psychiatry. 2002;  72 343-346
• 3 Sayed-Tabatabaei F A, Houwing-Duistermaat J J, van Duijn C M et al.. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis.  Stroke. 2003;  34 1634-1639
• 4 Carmelli D, DeCarli C, Swan G E et al.. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins.  Stroke. 1998;  29 1177-1181
• 5 Turner S T, Jack C R, Fornage M et al.. Heritability of leukoaraiosis in hypertensive sibships.  Hypertension. 2004;  43 483-487
• 6 Atwood L D, Wolf P A, Heard-Costa N L et al.. Genetic variation in white matter hyperintensity volume in the Framingham Study.  Stroke. 2004;  35 1609-1613
• 7 Fox C S, Polak J F, Chazaro I et al.. Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart Study.  Stroke. 2003;  34 397-401
• 8 Juo S H, Lin H F, Rundek T et al.. Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study.  Stroke. 2004;  35 2243-2247
• 9 Lange L A, Bowden D W, Langefeld C D et al.. Heritability of carotid artery intima-medial thickness in type 2 diabetes.  Stroke. 2002;  33 1876-1881
• 10 Hunt K J, Duggirala R, Goring H H et al.. Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study.  Stroke. 2002;  33 2775-2780
• 11 Moskau S, Golla A, Grothe C et al.. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families.  Stroke. 2005;  36 5-8
• 12 Zureik M, Ducimetiere P, Touboul P J et al.. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study.  Arterioscler Thromb Vasc Biol. 2000;  20 1622-1629
• 13 Adams Jr H P, Bendixen B H, Kappelle L J et al.. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST-Trial of Org 10172 in Acute Stroke Treatment.  Stroke. 1993;  24 35-41
• 14 The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators . Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial.  JAMA. 1998;  279 1265-1272
• 15 Adams Jr H P, Woolson R F, Clarke W R et al.. Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).  Control Clin Trials. 1997;  18 358-377
• 16 Barnett H J, Taylor D W, Eliasziw M et al.. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.  N Engl J Med. 1998;  339 1415-1425
• 17 Hart R G. Prevention of stroke in atrial fibrillation: an update.  Health Rep. 1994;  6 126-131
• 18 Kunitz S C, Gross C R, Heyman A et al.. The pilot Stroke Data Bank: definition, design, and data.  Stroke. 1984;  15 740-746
• 19 Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.  Stroke. 1988;  19 1083-1092
• 20 Caplan L R, Hier D B, D'Cruz I. Cerebral embolism in the Michael Reese Stroke Registry.  Stroke. 1983;  14 530-536
• 21 Mohr J P, Caplan L R, Melski J W et al.. The Harvard Cooperative Stroke Registry: a prospective registry.  Neurology. 1978;  28 754-762
• 22 Spitzer K, Becker V, Thie A et al.. The Hamburg Stroke Data Bank: goals, design and preliminary results.  J Neurol. 1989;  236 139-144
• 23 Gordon D L, Bendixen B H, Adams Jr H P et al.. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators.  Neurology. 1993;  43 1021-1027
• 24 Madden K P, Karanjia P N, Adams Jr H P et al.. Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment.  Neurology. 1995;  45 1975-1979
• 25 Lee L J, Kidwell C S, Alger J et al.. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography.  Stroke. 2000;  31 1081-1089
• 26 Goldstein L B, Jones M R, Matchar D B et al.. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.  Stroke. 2001;  32 1091-1097
• 27 Adams Jr H P, Davis P H, Leira E C et al.. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).  Neurology. 1999;  53 126-131
• 28 Lyden P, Brott T, Tilley B et al.. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.  Stroke. 1994;  25 2220-2226
• 29 Lovblad K O, Baird A E, Schlaug G et al.. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome.  Ann Neurol. 1997;  42 164-170
• 30 Schulz U G, Flossmann E, Rothwell P M. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies.  Stroke. 2004;  35 819-824
• 31 Meschia J F, Brott T G, Brown Jr R D et al.. The Ischemic Stroke Genetics Study (ISGS) protocol.  BMC Neurol. 2003;  3 4
• 32 Johnson C J, Kittner S J, McCarter R J et al.. Interrater reliability of an etiologic classification of ischemic stroke.  Stroke. 1995;  26 46-51
• 33 Kittner S J, Stern B J, Wozniak M et al.. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study.  Neurology. 1998;  50 890-894
• 34 Meschia J F. Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research.  Stroke. 2002;  33 2770-2774
• 35 Martiskainen M, Pohjasvaara T, Mikkelsson J et al.. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke.  Stroke. 2003;  34 886-891
• 36 Myllykangas L, Polvikoski T, Sulkava R et al.. Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.  Ann Med. 2001;  33 486-492
• 37 Gretarsdottir S, Sveinbjornsdottir S, Jonsson H H et al.. Localization of a susceptibility gene for common forms of stroke to 5q12.  Am J Hum Genet. 2002;  70 593-603
• 38 Gretarsdottir S, Thorleifsson G, Reynisdottir S T et al.. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.  Nat Genet. 2003;  35 131-138
• 39 Funalot B, Varenne O, Mas J L. A call for accurate phenotype definition in the study of complex disorders.  Nat Genet. 2004;  36 3 , author reply 3-4
• 40 Furlan A, Higashida R, Wechsler L et al.. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism.  JAMA. 1999;  282 2003-2011
• 41 Uchino K, Billheimer D, Cramer S C. Entry criteria and baseline characteristics predict outcome in acute stroke trials.  Stroke. 2001;  32 909-916
• 42 Casas J P, Hingorani A D, Bautista L E et al.. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls.  Arch Neurol. 2004;  61 1652-1661
• 43 http://locus.umdnj.edu/ninds Accessed March 11, 2005
• 44 Foulkes M A, Wolf P A, Price T R et al.. The Stroke Data Bank: design, methods, and baseline characteristics.  Stroke. 1988;  19 547-554
• 45 Bamford J, Sandercock P, Dennis M et al.. Classification and natural history of clinically identifiable subtypes of cerebral infarction.  Lancet. 1991;  337 1521-1526
• 46 Markus H S, Barley J, Lunt R et al.. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma.  Stroke. 1995;  26 1329-1333
• 47 Ito D, Murata M, Watanabe K et al.. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population.  Stroke. 2000;  31 936-939
• 48 Kokubo Y, Chowdhury A H, Date C et al.. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population.  Stroke. 2000;  31 1299-1306
• 49 Kessler C, Spitzer C, Stauske D et al.. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.  Arterioscler Thromb Vasc Biol. 1997;  17 2880-2884
• 50 Jannes J, Hamilton-Bruce M A, Pilotto L et al.. Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke.  Stroke. 2004;  35 1090-1094